Phosphodiesterase inhibitors vs placeboSeverity of attacks · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 111 participantsVery low